Medicine
Dobutamine 1000 mg/250 mL injection
Dobutamine 1000 mg/250 mL injection is a generic prescription medicine for intravenous use, made by 2 labelers, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Ambient
Protect from freezing. It is recommended the product be stored at room…
Key facts
- Active ingredient (INN)
- Dobutamine
- Brand
- Sold under the generic name
- Strength
- 1000 mg/250 mL
- Dosage form
- Injection
- Route
- Intravenous
- Packs
- 18 bags of 250 mL, 12 pouches of 250 mL
- Manufacturers
- Baxter HealthcareHospira
- Origin register
- US FDA, United States
- Storage
- Protect from freezing. It is recommended the product be stored at room temperature (25°C), brief exposure up to 40°C does not adversely affect the product.
- Cold chain
- Not required on record
- Prescription status
- Prescription only
- Controlled substance
- Not recorded as controlled
- ATC code
- C01CA07 Dobutamine
- HS code (indicative)
- 3004.90Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 23 September 1993
- Identifiers
- RxCUI 309985, 309986, 309987DailyMed set ID 6b17b98b-e06d-42ed-925f-69aa2699dead, 9943a961-3b50-4847-8a84-d8414ce38daaNDC 0338-1077, 0409-1100Application NDA020255, NDA020201
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
Packs from every labeler of this generic presentation.
| Pack | Code | Labeler | Marketed since |
|---|---|---|---|
| 18 bag in 1 carton / 250 mL in 1 bag | 0338-1077-02 | Baxter Healthcare | 27 September 1993 |
| 12 pouch in 1 case / 1 bag in 1 pouch / 250 mL in 1 bag | 0409-1100-10 | Hospira | 16 March 2026 |
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
| Register | Status | Source |
|---|---|---|
| US FDA | Listed, marketed | Source record for this pageChecked 12 November 2026 |
| US FDA | First approved 18 July 1978 | Drugs@FDA |
| EU (EMA) | Not recorded | — |
| India (CDSCO) | Not yet confirmed against CDSCO approval lists | — |
| United States | Registered | US FDA (NDC directory, openFDA)Checked 12 November 2026 |
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Other strengths and forms of Dobutamine
Clinical summary
Dobutamine is a beta-adrenergic agonist. It is available as injection for intravenous use. MedsAcross supplies Dobutamine for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about DobutamineFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- Dobutamine in Dextrose prescribing information (Hospira) · U.S. National Library of Medicine, DailyMed
Need Dobutamine 1000 mg/250 mL injection for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.